DS
INBX

David Shaw’s Inhibrx, Inc. Common Stock INBX Stock Holding History

David Shaw’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35,497
Closed -$922K – 4689
2023
Q2 		$922K Sell
35,497
-55,353
-61% -$1.29M ﹤0.01% 3145
2023
Q1 		$1.71M Sell
90,850
-10,390
-10% -$242K ﹤0.01% 2805
2022
Q4 		$2.49M Buy
101,240
+31,521
+45% +$927K ﹤0.01% 2751
2022
Q3 		$1.25M Sell
69,719
-51,293
-42% -$925K ﹤0.01% 3423
2022
Q2 		$1.37M Buy
121,012
+85,016
+236% +$1.25M ﹤0.01% 3402
2022
Q1 		$802K Buy
35,996
+22,187
+161% +$566K ﹤0.01% 4079
2021
Q4 		$603K Buy
+13,809
New +$552K ﹤0.01% 4295

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

David Shaw's INBX Position: Q3 2023 in Review

David Shaw sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2023, closing a stake of 35,497 shares — an estimated $922K sold.

David Shaw first reported a position in INBX in Q4 2021 and held it in 7 quarters. The position peaked at $2.49M in Q4 2022. 111 funds tracked by Wall St. Rank hold INBX as of Q3 2023.

  • David Shaw reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • David Shaw sold 35,497 Inhibrx, Inc. Common Stock shares in Q3 2023, an estimated $922K.
  • David Shaw first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • David Shaw's Inhibrx, Inc. Common Stock position peaked at $2.49M in Q4 2022.
  • 111 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.